While survivin, a dual regulator of cancer cell proliferation and cell death, is a transcriptional target of Wnt/β-catenin signaling [39, 40], overexpression of survivin has been reported as the mediator of radioresistance, and inhibition of survivin is associated with increased radiosensitivity in several types of cancer [41–46]. Here, BIRC5 is linked to cancer.